This is a sole-source purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Speed Biosystems, LLC, a minority-owned small disadvantaged business. The $146,860.00 firm-fixed-price contract is for the delivery of 46 units of TURBO293 Transfection Reagents, a specialized biological product used in coronavirus-related research, vaccine production, and immunogen development. The contract supports critical scientific work, primarily taking place at the Vaccine Research Center in Bethesda, Maryland. While no small business set-aside was used, Speed Biosystems has received over $3 million in federal contracts from NIH since 2019, demonstrating its unique capabilities in this domain. The sole-source award recognizes Speed Biosystems as the sole owner, developer, and seller of the required reagents, which are necessary for continued research protocols and compatibility requirements.
Generated 2/21/25, 9:50 AM